No and Nord smart small program "No and Care" officially launched

January 20th, No. 100, a company that has been involved in diabetes treatment for nearly a hundred years, officially launched a digital solution for diabetics, the "No. 1 Care" program, dedicated to becoming a "smart assistant" for diabetics and an "out-of-hospital helper" for doctors.The exploration of diabetes began more than 1500 years ago. One hundred years ago, with the discoverion of insulin, a life-saving drug, diabetes was no longer an incurable disease. Although the current level of care has been able to provide effective treatment options for patients, the treatment of diabetes is a long-lasting battle that requires multi-party cooperation and requires a high level of patient expertise and self-management. This is a common challenge for our country's more than 129 million "sugar friends".Diabetics: Less than a half are "in the throes" and less than a-half of blood sugar is up toAccording to figures published by the International Diabetes Federation (IDF), there are about 463 million people aged 20 to 79 worldwide with diabetes between the ages of 20 and 79, nearly half of whom are undiagnosed, and many have developed complications including eye, kidney and heart injuries when diagnosed with diabetes. In China, the total number of people with diabetes is estimated to have exceeded 129 million, ranking first in the world, due to lack of timely diagnosis, lack of adequate attention, not on time blood sugar monitoring and medication and other reasons, treatment rate and control rate are not ideal, at present, less than 16% of Chinese patients blood sugar control standards.Artificial intelligence and digital solutions: empowering patients, assisting doctorsThis status quo is related to many objective limitations of diabetes diagnosis and treatment: First, China's diabetes patients have a large base, uneven distribution of medical resources;Fortunately, the development of artificial intelligence and digital technology is constantly combined with existing diabetes diagnosis and treatment, which is expected to completely break the dilemma of diabetes management. Digital solutions truly empower patients, making it easier for them to acquire knowledge and communicate with professional doctors to help them manage their blood sugar with precision, controlling blood sugar, reducing complications and improving quality of life.“ No and care": small procedures, big careThis time No and Nord launched the "No and care" small program highlights include:intelligent companion management: to assist patients to record daily blood sugar, blood pressure, exercise records, etc., in a simple and convenient way to help patients develop self-management habits. Health reports, dietary inquiries, etc. guide patients to scientific treatment and always understand the patient's physical condition.Professional Diabetes Consultation Question and Answer: Customized individual courses according to the patient's drug treatment program to solve the patient's knowledge blind spot. At the same time, the diabetes intelligent patient education robot "Teacher Xiaono", developed jointly with Microsoft, gives patients access to professional and efficient diabetes counseling and question-and-answer services anywhere, 7 days a week, 24 hours a day.In addition, there are sugar circle, knowledge base and other sectors, will be the patient's care into every detail, to help patients achieve comprehensive self-management.In the future, based on artificial intelligence big data, "No and Care" will also be more "understand" the needs of every sugar friend, for sugar friends to provide different individual service support.With the help of new tools and AI technology, patients' daily health management will be easier. This is also the new achievement of No. and Nord responding to the call for "Internet plus Healthcare", accelerating the pace of digital innovation and exploring digital solutions in the field of diabetes."For nearly a hundred years, No. 1 and NORD's innovations have been unstoed and we are committed to 'changing diabetes' to help patients access more efficient and convenient diabetes solutions," said Zhou Xiaping, Senior Vice President and President of No. Today, the day-to-day self-management of diabetics will be transformed by artificial intelligence and digital technology. We look forward to working with industry partners to enable hundreds of millions of diabetics to enjoy a quality of life. ”[1] Yongze Li, et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study. Bmj. 2020, 369 :m997.[2] IDF Diabetes Atlas, 9th edn. International Diabetes Federation, 2019. Founded in 1923, Noor and Nord, Noor and Nord are the world's leading biopharmaceutical companies headquartered in Denmark. Our goal is to drive change to fight diabetes, obesity, rare blood disorders, endocrine disorders and other serious chronic diseases. To achieve this goal, we lead scientific breakthroughs, expand the company's access to medicines, and are committed to preventing and ultimately curing diseases. Noor and NORD employ approximately 44,000 people in 80 countries and provide products and services to more than 170 countries and territories worldwide. Source: Noel and Nord